(Q73950107)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9403020%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

title

Recombinant human erythropoietin for the treatment of anemia in children with solid malignant tumors (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9403020%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

author name string

P León

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9403020%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

M Jiménez

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9403020%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

P Barona

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9403020%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

L Sierrasesúmaga

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9403020%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

publication date

1 February 1998

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9403020%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

published in

Pediatric Blood Cancer

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9403020%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

volume

30

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9403020%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9403020%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

page(s)

110-116

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9403020%20AND%20SRC:MED&resulttype=core&format=json

Hematopoietic growth factors and the treatment of tumor-associated anemias

8 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-911X%28199802%2930%3A2%3C110%3A%3AAID-MPO8%3E3.0.CO%3B2-L

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-911X%28199802%2930%3A2%3C110%3A%3AAID-MPO8%3E3.0.CO%3B2-L

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-911X%28199802%2930%3A2%3C110%3A%3AAID-MPO8%3E3.0.CO%3B2-L

Decreased erythropoietin response in patients with the anemia of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-911X%28199802%2930%3A2%3C110%3A%3AAID-MPO8%3E3.0.CO%3B2-L

The frequency of red cell transfusion for anemia in patients receiving chemotherapy. A retrospective cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-911X%28199802%2930%3A2%3C110%3A%3AAID-MPO8%3E3.0.CO%3B2-L

Special report: transfusion risks

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-911X%28199802%2930%3A2%3C110%3A%3AAID-MPO8%3E3.0.CO%3B2-L

The risk of transfusion-transmitted infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-911X%28199802%2930%3A2%3C110%3A%3AAID-MPO8%3E3.0.CO%3B2-L

Estimated risk of transmission of the human immunodeficiency virus by screened blood in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-911X%28199802%2930%3A2%3C110%3A%3AAID-MPO8%3E3.0.CO%3B2-L

Correction of the anemia of end-stage renal disease with recombinant human erythropoietin. Results of a combined phase I and II clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-911X%28199802%2930%3A2%3C110%3A%3AAID-MPO8%3E3.0.CO%3B2-L

Recombinant human erythropoietin for patients with AIDS treated with zidovudine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-911X%28199802%2930%3A2%3C110%3A%3AAID-MPO8%3E3.0.CO%3B2-L

Study of erythropoietin in treatment of anaemia in patients with rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-911X%28199802%2930%3A2%3C110%3A%3AAID-MPO8%3E3.0.CO%3B2-L

Erythropoietin for anaemia in cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-911X%28199802%2930%3A2%3C110%3A%3AAID-MPO8%3E3.0.CO%3B2-L

Recombinant human erythropoietin treatment in cisplatin-associated anemia: a randomized, double-blind trial with placebo

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-911X%28199802%2930%3A2%3C110%3A%3AAID-MPO8%3E3.0.CO%3B2-L

Erythropoiesis in multiple myeloma: defective red cell production due to inappropriate erythropoietin production

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-911X%28199802%2930%3A2%3C110%3A%3AAID-MPO8%3E3.0.CO%3B2-L

Recombinant human erythropoietin for the correction of cancer associated anemia with and without concomitant cytotoxic chemotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-911X%28199802%2930%3A2%3C110%3A%3AAID-MPO8%3E3.0.CO%3B2-L

Recombinant human erythropoietin in the treatment of cancer-related anaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-911X%28199802%2930%3A2%3C110%3A%3AAID-MPO8%3E3.0.CO%3B2-L

Recombinant human erythropoietin and the anemia of multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-911X%28199802%2930%3A2%3C110%3A%3AAID-MPO8%3E3.0.CO%3B2-L

Cisplatin-associated anaemia treated with subcutaneous erythropoietin. A pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-911X%28199802%2930%3A2%3C110%3A%3AAID-MPO8%3E3.0.CO%3B2-L

Recombinant erythropoietin in acute chemotherapy-induced anemia of children with cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-911X%28199802%2930%3A2%3C110%3A%3AAID-MPO8%3E3.0.CO%3B2-L

Erythropoietin for the treatment of anemia of malignancy associated with neoplastic bone marrow infiltration

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-911X%28199802%2930%3A2%3C110%3A%3AAID-MPO8%3E3.0.CO%3B2-L

Recombinant human erythropoietin therapy for anemic cancer patients on combination chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-911X%28199802%2930%3A2%3C110%3A%3AAID-MPO8%3E3.0.CO%3B2-L

Erythropoietin treatment of anemia associated with multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-911X%28199802%2930%3A2%3C110%3A%3AAID-MPO8%3E3.0.CO%3B2-L

Quality of life in chronic anemia of cancer during treatment with recombinant human erythropoietin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-911X%28199802%2930%3A2%3C110%3A%3AAID-MPO8%3E3.0.CO%3B2-L

10.1002/(SICI)1096-911X(199802)30:2<110::AID-MPO8>3.0.CO;2-L

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9403020%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

1 reference